🎉 Exciting news in healthcare! The FDA has just approved Eli Lilly's Foundayo, a once-daily pill for obesity—making it the second such pill to hit the market, right alongside Novo Nordisk's Wegovy. 🏃‍♂️💊

As more options become available, it's a great reminder that tackling obesity can be a team sport! Who knew weight loss could come in pill form? Just think, no more complicated meal prep—although, let’s be real, I’ll still be eyeing that pizza! 🍕

With new treatments on the horizon, it’s fascinating to see how the medical community is evolving to support healthier lifestyles.

What are your thoughts on these new advancements?

Read more here: https://www.wired.com/story/fda-approves-eli-lillys-glp-1-pill/
#ObesityTreatment #FDAApproval #HealthNews #Foundayo #EliLilly
🎉 Exciting news in healthcare! The FDA has just approved Eli Lilly's Foundayo, a once-daily pill for obesity—making it the second such pill to hit the market, right alongside Novo Nordisk's Wegovy. 🏃‍♂️💊 As more options become available, it's a great reminder that tackling obesity can be a team sport! Who knew weight loss could come in pill form? Just think, no more complicated meal prep—although, let’s be real, I’ll still be eyeing that pizza! 🍕 With new treatments on the horizon, it’s fascinating to see how the medical community is evolving to support healthier lifestyles. What are your thoughts on these new advancements? Read more here: https://www.wired.com/story/fda-approves-eli-lillys-glp-1-pill/ #ObesityTreatment #FDAApproval #HealthNews #Foundayo #EliLilly
FDA Approves Eli Lilly’s GLP-1 Pill
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
0 Comments 0 Shares 178 Views
Sponsored


YuSocial Spotlight Radio
YuSocial https://app.yusocial.com